Advances in human proteomics at high scale with the SOMAscan proteomics platform

New Biotechnology

Volumn 29, Issue 5, 2012, Pages 543-549

  Gold, Larry ^a,b   Walker, Jeffrey J ^a   Wilcox, Sheri K ^a   Williams, Stephen ^a  

^a SomaLogic Inc   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIO-MARKER DISCOVERY; GENOMICS; HUMAN MATRIX; HUMAN PROTEOME; PROTEOMICS; TISSUE EXTRACTS;

DIAGNOSIS; HEALTH CARE; MOLECULAR BIOLOGY; NUCLEIC ACIDS; TISSUE;

PROTEINS;

DEXTRAN SULFATE; RIBOZYME; SINGLE STRANDED DNA; SMALL INTERFERING RNA;

AREA UNDER THE CURVE; ARTICLE; CEREBROSPINAL FLUID; CHEMICAL MODIFICATION; CHRONIC KIDNEY DISEASE; CONCENTRATION (PARAMETERS); CROSS REACTION; DNA MICROARRAY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOMICS; HISTOCHEMISTRY; HUMAN; IN VITRO STUDY; LIMIT OF QUANTITATION; LUNG NON SMALL CELL CANCER; MASS SPECTROMETRY; MICROFLUIDICS; MOLECULAR RECOGNITION; PH; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN TARGETING; PROTEOMICS; REPRODUCIBILITY; SCALE UP; SENSITIVITY AND SPECIFICITY; SERUM; SOMASCAN; ULTRAVIOLET IRRADIATION;

BIOLOGICAL MARKERS; DNA; HUMANS; PROTEINS; PROTEOMICS;

EID: 84862024643     PISSN: 18716784     EISSN: 18764347     Source Type: Journal    
DOI: 10.1016/j.nbt.2011.11.016     Document Type: Article

References (54)

1. Nabel G.J. The coordinates of truth. Science 2009, 326:53-54.
2. Lander A.D. The edges of understanding. BMC Biology 2010, 8:40.
3. Glass D.J. A critique of the hypothesis, and a defense of the question, as a framework for experimentation. Clinical Chemistry 2010, 56:1080-1085.
4. Kell D.B., Oliver S.G. Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. BioEssays 2004, 26:99-105.
5. Brody E.N., Gold L., Lawn R.M., Walker J.J., Zichi D. High-content affinity-based proteomics: unlocking protein biomarker discovery. Expert Review of Molecular Diagnostics 2010, 10:1013-1022.
6. Brody E.N., et al. The use of aptamers in large arrays for molecular diagnostics. Molecular Diagnosis: a journal devoted to the understanding of human disease through the clinical application of molecular biology 1999, 4:381-388.
7. Zichi D., Eaton B., Singer B., Gold L. Proteomics and diagnostics: Let's Get Specific, again. Current Opinion in Chemical Biology 2008, 12:78-85.
8. Addona T.A., et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nature Biotechnology 2009, 27:633-641.
9. Aebersold R. A stress test for mass spectrometry-based proteomics. Nature Methods 2009, 6:411-412.
10. Bell A.W., et al. HUPO test sample study reveals common problems in mass spectrometry-based proteomics. Nature Methods 2009, 6:423-430.
11. Liotta L.A., Petricoin E.F. Mass spectrometry-based protein biomarker discovery and measurement: sensitivity is the greatest hurdle. Clinical Proteomics 2010, 6:4-5.
12. Mitchell P. Proteomics retrenches. Nature Biotechnology 2010, 28:665-670.
13. Pan S., et al. Mass spectrometry based targeted protein quantification: methods and applications. Journal of Proteome Research 2009, 8:787-797.
14. Service R.F. Proteomics ponders prime time. Science 2008, 321:1758-1761.
15. Silberring J., Ciborowski P. Biomarker discovery and clinical proteomics. Trends in Analytical Chemistry 2010, 29:128.
16. Wheeler D.A., et al. The complete genome of an individual by massively parallel DNA sequencing. Nature 2008, 452:872-876.
17. Shendure J., Ji H. Next-generation DNA sequencing. Nature Biotechnology 2008, 26:1135-1145.
18. Uhlen M., et al. Towards a knowledge-based Human Protein Atlas. Nature Biotechnology 2010, 28:1248-1250.
19. Uhlen M., Svahn H.A. Affinity reagents for lab on chips. Lab on a Chip 2011, 11:1417.
20. Hood L., et al. Systems biology and new technologies enable predictive and preventative medicine. Science 2004, 306:640-643.
21. Anderson N.L. The human plasma proteome: history, character, and diagnostic prospects. Molecular & Cellular Proteomics 2002, 1:845-867.
22. Eaton B.E., Gold L., Zichi D.A. Let's get specific: the relationship between specificity and affinity. Chemistry & Biology 1995, 2:633-638. 10.1016/S0031-9406(05)67026-5.
23. Hall B.D., Spiegelman S. Sequence complementarity of T2-DNA and T2-specific RNA. Proceedings of the National Academy of Sciences of the United States of America 1961, 47:137-163.
24. Schena M., Shalon D., Davis R.W., Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270:467-470.
25. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. The Journal of Biological Chemistry 1975, 250:4007-4021.
26. Nilsson T., et al. Mass spectrometry in high-throughput proteomics: ready for the big time. Nature Methods 2010, 7:681-685.
27. Domon B., Aebersold R. Options and considerations when selecting a quantitative proteomics strategy. Nature Biotechnology 2010, 28:710-721.
28. Cox J., Mann M. Quantitative, high-resolution proteomics for data-driven systems biology. Annual Review of Biochemistry 2011, 80:273-299.
29. Anderson N.L., et al. Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). Journal of Proteome Research 2004, 3:235-244.
30. Chait B.T. Mass spectrometry in the postgenomic era. Annual Review of Biochemistry 2011, 80:239-246.
31. Whiteaker J.R., et al. A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nature Biotechnology 2011, 29:625-634.
32. Anderson N.L., et al. ISCAPA peptide enrichment on magnetic beads using an in-line bead trap device. Molecular & Cellular Proteomics 2009, 8:995-1005.
33. Whiteaker J.R. Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry. Molecular & Cellular Proteomics 2011, 10. M110.005645.
34. Whiteaker J.R., Zhao L., Anderson L., Paulovich A.G. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Molecular & Cellular Proteomics 2010, 9:184-196.
35. Editors (2011) Profile - Lee Hood. Nature Biotechnology 29, 191.
36. Schweitzer B., et al. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nature Biotechnology 2002, 20:359-365.
37. Fredriksson S., et al. Multiplexed protein detection by proximity ligation for cancer biomarker validation. Nature Methods 2007, 4:327-329.
38. Borrebaeck C.A.K., Wingren C. High-throughput proteomics using antibody microarrays: an update. Expert Review of Molecular Diagnostics 2007, 7:673-686.
39. Gold L., et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One 2010, 5:e15004.
40. Wilson R. High-content aptamer-based proteomics. Journal of Proteomics 2011, 5-7.
41. Hare P. Aptamer-based proteomics arrays. Nature Biotechnology 2011, 29:43.
42. Ostroff R.M., et al. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer. PLoS One 2010, 5:e15003.
43. Kraemer S., Vaught J.D., Bock C. From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay. PLoS One 2011, 6:e26332.
44. Ninio J. Kinetic amplification of enzyme discrimination. Biochimie 1975, 57:587-595.
45. Hopfield J.J. Kinetic proofreading: a new mechanism for reducing errors in biosynthetic processes requiring high specificity. Proceedings of the National Academy of Sciences of the United States of America 1974, 71:4135-4139.
46. Binz H.K., Amstutz P., Plückthun A. Engineering novel binding proteins from nonimmunoglobulin domains. Nature Biotechnology 2005, 23:1257-1268.
47. Ruigrok V.J.B., et al. Alternative affinity tools: more attractive than antibodies. Biochemical Journal 2011, 436:1-13.
48. Fodey T., et al. Developments in the production of biological and synthetic binders for immunoassay and sensor-based detection of small molecules. Trends in Analytical Chemistry 2011, 30:254-269.
49. Seurynck-Servoss S.L., et al. Evaluation of surface chemistries for antibody microarrays. Analytical Biochemistry 2007, 371:105-115.
50. Vaught J.D., et al. Expanding the chemistry of DNA for in vitro selection. Journal of American Chemical Society 2010, 132:4141-4151.
51. Vaught J.D., Dewey T., Eaton B.E. T7 RNA polymerase transcription with 5-position modified UTP derivatives. Journal of American Chemical Society 2004, 126:11231-11237.
52. Ostroff R., et al. The stability of the circulating human proteome to variations in sample collection and handling procedures measured with an aptamer-based proteomics array. Journal of Proteomics 2010, 73:649-666.
53. Gupta S., et al. Rapid histochemistry using slow off-rate modified aptamers with anionic competition. Applied Immunohistochemistry & Molecular Morphology 2011, 19:273-278.
54. Mehan MR, et al. Protein signature of lung cancer tissues (submitted for publication).